TY - JOUR
T1 - Efficacy and safety of eplerenone in heart failure management
AU - Zheng, Jin
AU - Wang, Shuangao
AU - Timóteo, Ana Teresa
N1 - Zheng, J., Wang, S., & Timóteo, A. T. (2024). Efficacy and safety of eplerenone in heart failure management. European Journal Of Internal Medicine, 123, 163-164. Advance online publication. https://doi.org/10.1016/j.ejim.2024.02.006
PY - 2024/5/1
Y1 - 2024/5/1
N2 - Heart failure (HF) is a clinical syndrome characterized primarily by breathlessness, fatigue, and congestion. Since the 20th century, there has been an increasing trend in the incidence of HF. Despite significant advancements in the treatment of HF in recent years, chronic HF remains a life-threatening disease and continues to challenge healthcare professionals. Research on eplerenone is important because it addresses a significant unmet medical need: the effective management of heart failure, a condition that affects millions of people worldwide and carries a high mortality rate.
AB - Heart failure (HF) is a clinical syndrome characterized primarily by breathlessness, fatigue, and congestion. Since the 20th century, there has been an increasing trend in the incidence of HF. Despite significant advancements in the treatment of HF in recent years, chronic HF remains a life-threatening disease and continues to challenge healthcare professionals. Research on eplerenone is important because it addresses a significant unmet medical need: the effective management of heart failure, a condition that affects millions of people worldwide and carries a high mortality rate.
UR - http://www.scopus.com/inward/record.url?scp=85191094034&partnerID=8YFLogxK
UR - https://www.webofscience.com/wos/woscc/full-record/WOS:001240068000001
U2 - 10.1016/j.ejim.2024.02.006
DO - 10.1016/j.ejim.2024.02.006
M3 - Letter
C2 - 38365517
SN - 0953-6205
VL - 123
SP - 163
EP - 164
JO - European Journal Of Internal Medicine
JF - European Journal Of Internal Medicine
ER -
